Telehealth Extensions & 2026 Compliance Priorities: A Compliance Cliffs Update

Telehealth Extensions & 2026 Compliance Priorities: A Compliance Cliffs Update

From 1st Talk Compliance by First Healthcare Compliance

February 4, 2026 · 20 min

About this episode

This episode provides updates on telehealth flexibilities and compliance priorities for 2026.

In this episode of 1st Talk Compliance , Kevin Chmura is joined by Robyn Johns, as they discuss recent updates to their November live webinar, Compliance Cliffs: Navigating Telehealth Waivers and Reimbursement Changes. Learn how the policy landscape has shifted in recent months—especially around telehealth flexibilities, controlled substance prescribing, and the 2026 CMS payment rules.   Kevin Chmura Welcome to 1st Talk Compliance. I’m Kevin Chmura, CEO of Panacea Healthcare Solutions. Today we’re bringing you a timely update on our November live webinar, Compliance Cliffs: Navigating Telehealth Waivers and Reimbursement Changes. Since that webinar, several policy changes have moved quickly, especially in telehealth flexibilities. Controlled substance prescribing and 2026 CMS payment rules. Before we jump in, just a quick note. 1st Talk Compliance is brought to you by 1st Healthcare Compliance, a part of Panacea Healthcare Solutions. We help healthcare organizations strengthen their compliance programs with practical education tools and compliance management support. So teams can reduce risk, keep pace with regulatory change and operate with confidence. Now…

People in this episode

Host: Kevin Chmura

Guest: Robyn Johns

Topics covered

  • telehealth
  • compliance
  • healthcare policy
  • controlled substances
  • CMS payment rules

Keywords

  • telehealth
  • compliance
  • controlled substances
  • CMS
  • healthcare

Sponsors

1st Healthcare Compliance

Mentioned in this episode

Organizations: 1st Healthcare Compliance, Panacea Healthcare Solutions, Med USA

Explore listener stats, chart rankings, contacts and more on the 1st Talk Compliance podcast page.